{"id":"W4392015401","doi":"10.1159/000537966","title":"Tislelizumab versus Sorafenib in First-Line Treatment of Unresectable Hepatocellular Carcinoma: Impact on Health-Related Quality of Life in RATIONALE-301 Study","year":2024,"lang":"en","type":"article","venue":"Liver Cancer","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre; Toronto General Hospital","funders":"National Cancer Institute; BeiGene","keywords":"Sorafenib; Hepatocellular carcinoma; Medicine; Quality of life (healthcare); Internal medicine; Oncology; Carcinoma","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003130226,0.001043735,0.002249715,0.0002696927,0.000286801,0.0007699461,0.0007085621,0.0009342249,0.005174889],"category_scores_gemma":[0.002041827,0.0004230346,0.003447046,0.0003321711,0.0004612832,0.0006070304,0.0004254437,0.002516636,0.0007300454],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001039101,"about_ca_system_score_gemma":0.001791655,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001034574,"about_ca_topic_score_gemma":0.004464413,"domain_scores_codex":[0.9987063,0.0009421814,0.00005851002,0.0001024541,0.00009520982,0.00009532702],"domain_scores_gemma":[0.9984758,0.0003320824,0.0004887567,0.0001336185,0.0001283535,0.0004413631],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.9278312,0.009563359,0.005206884,0.001523611,0.005453332,0.00008125103,0.00007194188,0.000942603,0.006950764,0.0001661268,0.003410547,0.03879845],"study_design_scores_gemma":[0.7799028,0.178545,0.0317938,0.0001829716,0.004106008,0.0001723856,0.0000548694,0.001514127,0.001036943,0.0002302809,0.002405652,0.00005524634],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9853586,0.006333047,0.0004575905,0.001281669,0.000334792,0.001500465,0.002374961,0.00008217133,0.002276765],"genre_scores_gemma":[0.9897951,0.002267245,0.0008814629,0.0008818666,0.0002781792,0.001474116,0.002396122,0.00002175307,0.002003947],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005174889,"threshold_uncertainty_score":0.01731169,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1663480367441998,"score_gpt":0.3602734384689181,"score_spread":0.1939254017247184,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}